Search

everythinglearnresearchcommunity

for

Search:↓

The study found no link between anxiety, vitamin B12, folate, TSH, ferritin, zinc levels, and trichodynia in telogen alopecia patients.

Trichoscopy helps tell apart other hair loss conditions from common hair loss.

Psychological factors like depression may be more important than zinc, folate, and vitamin B12 levels in causing scalp pain in people with hair loss.

H-1 antihistamines may help with various skin conditions, but more research is needed to confirm their effectiveness.

Trichoscopy is a useful tool for diagnosing hair disorders without pulling out hair.

The document concludes that different types of permanent hair loss conditions are related and early treatment is key to preventing further damage.

Sensitive skin is often caused by nerve fibers and environmental factors, and can be managed with mild skincare and professional advice.

The article concludes that dermatologists should prescribe lifestyle drugs carefully and consider mental health treatments for patients with disorders like BDD.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Synthetic cannabinoid addiction can cause skin problems like acne and hair loss.

Hair diseases can have psychological effects and should be treated with a combination of psychosomatic care, therapy, and medication.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

The document concludes that treating skin conditions should include psychological care and a multidisciplinary approach is essential for effective management.

New understanding and treatments for hair loss are improving, but more research is needed.

The document concludes that we need more research to understand Telogen Effluvium and find effective treatments.

Sensitive skin often causes discomfort, affects many people, especially women and older adults, and should be managed with careful product selection.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

No treatment showed clear superiority for lichen planopilaris.

A new variant of lichen planopilaris causing diffuse hair thinning was identified.

For sensitive scalp, treatment is personalized and may include specific medications and hydration, while avoiding stress and irritating products.

The document suggests that nerve issues might contribute to hair loss and that testing sensation could predict these nerve problems.

Primary essential CVG is a rare, benign scalp condition with treatment focusing on symptom management and hygiene.

Both Follicular Unit Transplantation (FUT) and Follicular Unit Excision (FUE) are effective hair transplant methods; the best choice depends on the patient's needs and the surgeon's preference.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

The document concludes that choosing the right forehead and brow lifting technique based on individual patient characteristics is crucial to prevent complications and achieve desired results.

Recognizing congenital triangular alopecia is crucial to avoid unnecessary treatments.